awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41149668-56D12E77-0724-4B48-8144-6342D8CC3B7B
Q41149668-56D12E77-0724-4B48-8144-6342D8CC3B7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41149668-56D12E77-0724-4B48-8144-6342D8CC3B7B
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
P2860
Q41149668-56D12E77-0724-4B48-8144-6342D8CC3B7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41149668-56D12E77-0724-4B48-8144-6342D8CC3B7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5baa238dd5d87b7eb52fd931f57f2abaeaf803c8
P2860
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.